Literature DB >> 19280193

Value of multidetector computed tomography evaluation of myocardial perfusion in the assessment of ischemic heart disease: comparison with nuclear perfusion imaging.

Nadjia Kachenoura1, Joseph A Lodato, Tamar Gaspar, Dianna M E Bardo, Barbara Newby, Sarah Gips, Nathan Peled, Roberto M Lang, Victor Mor-Avi.   

Abstract

MDCT-derived myocardial perfusion has not yet been validated against accepted standards. We developed a technique for quantification of myocardial perfusion from MDCT images and studied its diagnostic value against SPECT myocardial perfusion imaging (MPI). Ninety-eight patients were studied. Abnormal perfusion was detected by comparing normalized segmental x-ray attenuation against values obtained in 20 control subjects. Disagreement with resting MPI was investigated in relationship to MDCT image quality, severity of MPI abnormalities, and stress MPI findings. Resting MPI detected mild or worse abnormalities in 20/78 patients. MDCT detected abnormalities in 15/20 patients (sensitivity of 0.75). Most abnormalities missed by MDCT analysis were graded as mild on MPI. Additional abnormalities found in 16/78 patients were not confirmed on resting MPI (specificity of 0.72). However, 8 of these 16 apparently false positive MDCT perfusion tests had abnormal stress MPI; of these 8 patients, 7 had optimal MDCT image quality, while in 6/8 remaining patients, image quality was suboptimal. When compared with resting MPI, MDCT detected perfusion abnormalities with high accuracy. Moreover, half of MDCT perfusion abnormalities not confirmed by resting MPI were associated with abnormal stress MPI. Importantly, this information can be obtained without additional radiation dose or contrast agent.

Entities:  

Mesh:

Year:  2009        PMID: 19280193     DOI: 10.1007/s00330-009-1365-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results.

Authors:  Konstantin Nikolaou; Javier Sanz; Michael Poon; Bernd J Wintersperger; Bernd Ohnesorge; Teresa Rius; Zahi A Fayad; Maximilian F Reiser; Christoph R Becker
Journal:  Eur Radiol       Date:  2005-03-18       Impact factor: 5.315

3.  Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging.

Authors:  Andreas H Mahnken; Ralf Koos; Marcus Katoh; Joachim E Wildberger; Elmar Spuentrup; Arno Buecker; Rolf W Günther; Harald P Kühl
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

4.  Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.

Authors:  Albert C Lardo; Marco A S Cordeiro; Caterina Silva; Luciano C Amado; Richard T George; Anastasios P Saliaris; Karl H Schuleri; Veronica R Fernandes; Menekhem Zviman; Saman Nazarian; Henry R Halperin; Katherine C Wu; Joshua M Hare; Joao A C Lima
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

Review 5.  Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology.

Authors:  Stephen Schroeder; Stephan Achenbach; Frank Bengel; Christof Burgstahler; Filippo Cademartiri; Pim de Feyter; Richard George; Philipp Kaufmann; Andreas F Kopp; Juhani Knuuti; Dieter Ropers; Joanne Schuijf; Laurens F Tops; Jeroen J Bax
Journal:  Eur Heart J       Date:  2007-12-15       Impact factor: 29.983

6.  Multidetector computed tomography myocardial perfusion imaging during adenosine stress.

Authors:  Richard T George; Caterina Silva; Marco A S Cordeiro; Anthony DiPaula; Douglas R Thompson; William F McCarthy; Takashi Ichihara; Joao A C Lima; Albert C Lardo
Journal:  J Am Coll Cardiol       Date:  2006-06-21       Impact factor: 24.094

7.  Comparison of spiral multidetector CT angiography and myocardial perfusion imaging in the noninvasive detection of functionally relevant coronary artery lesions: first clinical experiences.

Authors:  Marcus Hacker; Tobias Jakobs; Florian Matthiesen; Christian Vollmar; Konstantin Nikolaou; Christoph Becker; Andreas Knez; Thomas Pfluger; Maximilian Reiser; Klaus Hahn; Reinhold Tiling
Journal:  J Nucl Med       Date:  2005-08       Impact factor: 10.057

8.  Sixty-four-MSCT in the characterization of porcine acute and subacute myocardial infarction: determination of transmurality in comparison to magnetic resonance imaging and histopathology.

Authors:  H Brodoefel; B Klumpp; A Reimann; M Fenchel; M Heuschmid; S Miller; S Schroeder; C Claussen; A M Scheule; A F Kopp
Journal:  Eur J Radiol       Date:  2006-12-21       Impact factor: 3.528

9.  Assessment of the myocardium on 2-phase cardiac multidetector computed tomography: does cyclic cardiac contraction influence myocardial attenuation?

Authors:  Daniel T Boll; Elmar M Merkle; Erik K Paulson; Martin H Hoffmann
Journal:  J Comput Assist Tomogr       Date:  2008 Jul-Aug       Impact factor: 1.826

10.  Combined functional and morphological imaging consisting of gated myocardial perfusion SPECT and 16-detector multislice spiral CT angiography in the noninvasive evaluation of coronary artery disease: first experiences.

Authors:  Marcus Hacker; Tobias Jakobs; Florian Matthiesen; Konstantin Nikolaou; Christoph Becker; Andreas Knez; Reinhold Tiling
Journal:  Clin Imaging       Date:  2007 Sep-Oct       Impact factor: 1.605

View more
  7 in total

1.  Myocardial hypo-enhancement on resting computed tomography angiography images accurately identifies myocardial hypoperfusion.

Authors:  Joshua L Busch; Adam M Alessio; James H Caldwell; Mohit Gupta; Songshou Mao; Jigar Kadakia; William Shuman; Matthew J Budoff; Kelley R Branch
Journal:  J Cardiovasc Comput Tomogr       Date:  2011-10-24

2.  Advances in quantitative assessment of myocardial blood flow and coronary reserve.

Authors:  Giovanni Lucignani; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

3.  Commentary on: delayed enhancement imaging of myocardial viability: low-dose high-pitch CT versus MRI.

Authors:  Florian Wolf
Journal:  Eur Radiol       Date:  2011-05-15       Impact factor: 5.315

Review 4.  Cardiac CT for myocardial ischaemia detection and characterization--comparative analysis.

Authors:  A M Bucher; C N De Cecco; U J Schoepf; R Wang; F G Meinel; S R Binukrishnan; J V Spearman; T J Vogl; B Ruzsics
Journal:  Br J Radiol       Date:  2014-08-19       Impact factor: 3.039

5.  Volumetric quantification of myocardial perfusion using analysis of multi-detector computed tomography 3D datasets: comparison with nuclear perfusion imaging.

Authors:  Nadjia Kachenoura; Federico Veronesi; Joseph A Lodato; Cristiana Corsi; Rupa Mehta; Barbara Newby; Roberto M Lang; Victor Mor-Avi
Journal:  Eur Radiol       Date:  2009-08-27       Impact factor: 5.315

Review 6.  Myocardial perfusion imaging with cardiac computed tomography: state of the art.

Authors:  Amit R Patel; Nicole M Bhave; Victor Mor-Avi
Journal:  J Cardiovasc Transl Res       Date:  2013-08-21       Impact factor: 4.132

7.  Update on Computed Tomography Myocardial Perfusion Imaging.

Authors:  Amita Singh; Victor Mor-Avi; Amit R Patel
Journal:  Curr Cardiovasc Imaging Rep       Date:  2016-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.